GLP-1 side effects: timeline and how to manage nausea

Week 1–4: the titration window

The first dose of Mounjaro (2.5mg) or Wegovy (0.25mg) is what we call a 'starter' dose — not enough to produce meaningful weight loss on its own, but enough to introduce your body to the molecule and let receptor activity build up. Most side effects cluster in this window because the receptors in your gut are encountering GLP-1 (and, for Mounjaro, GIP) agonism for the first time at a level your endogenous hormones never reach.

What's typical in weeks 1–4:

• Nausea: The headline symptom. Around 30% of patients report some nausea; perhaps 10% find it significant. Peaks in the 24–72 hours after each injection and settles between doses.
• Indigestion / heartburn: Common. Reflects slower gastric emptying.
• Constipation: Slower gut motility overall. Affects perhaps 20% of patients.
• Reduced appetite: Often dramatic. Many patients describe forgetting to eat. This is the therapeutic effect — but it can feel disorienting if you're not prepared for it.
• Mild fatigue: Often related to reduced calorie intake rather than the drug directly. Settles as you find your new equilibrium.
• Injection site reactions: Mild redness, occasional bruising. Rarely problematic.

Week 4–8: most symptoms settle

By around week four to six, most patients have adapted. The next dose step (Mounjaro 5mg or Wegovy 0.5mg) is usually better tolerated than the first — not because it's a lower dose, but because your receptors have downregulated and gastric emptying has adjusted. Some patients find the first 48 hours after each dose increase brings back mild nausea before settling, but the absolute intensity reduces over time.

By week eight most patients are in a new equilibrium: smaller portions feel natural, appetite is meaningfully reduced, sleep is often improved, and energy returns. This is the period where the weight loss really starts to compound — the trial curves are steepest between weeks 8 and 36.

If you're still nauseated daily by week eight, that's a signal to slow titration or hold the current dose for an extra month before stepping up. We adjust schedules individually.

Later side effects: gallbladder, pancreatitis, sulphur burps

Some side effects emerge later, often weeks or months into treatment.

Gallbladder problems (gallstones, cholecystitis): Rare but real. Affects about 0.5% of patients in trial data, possibly higher in real-world use. The mechanism is partly direct drug effect and partly rapid weight loss itself (any rapid loss raises gallstone risk). Symptoms: sharp pain in the right upper abdomen, especially after fatty meals, sometimes radiating to the right shoulder. If you have these, call us.

Pancreatitis: Very rare. The classic presentation is severe upper abdominal pain radiating through to the back, often with vomiting, that doesn't ease with rest. Trial incidence under 0.1% per patient-year. If this is your symptom picture, go to A&E — don't wait for our next appointment.

Sulphur burps: Less serious but very unpleasant. The slow gastric emptying allows protein and sulphur-containing foods to ferment for longer than usual, producing hydrogen sulphide gas. Smaller portions, lower red-meat intake on injection day, and shifting injection to evening rather than morning all help.

Hair shedding: Some patients notice diffuse hair thinning 3–6 months in. This is telogen effluvium — the response to rapid weight loss, not a direct drug effect. It resolves as weight stabilises. Adequate protein intake and addressing any iron or ferritin deficiency (see our blood-test results guide) helps.

Practical nausea management

The single most useful piece of advice: eat less, more often, lower fat. The mechanism is gastric emptying — a small meal exits the stomach faster than a large one, even with slowed motility. Fatty meals stay in the stomach longest and provoke the most nausea.

• Portion size: Half what you'd normally eat. Stop when comfortable, not full.
• Frequency: 4–5 small meals rather than three large ones.
• Composition: Lean protein, vegetables, complex carbs. Limit fatty meats, fried foods, creamy sauces and rich desserts especially in the 48 hours after each injection.
• Hydration: Sip water throughout the day. Easier than gulping large amounts. Aim for clear or pale urine.
• Timing: Some patients find injecting in the evening before bed reduces conscious experience of next-day nausea — you sleep through the peak.
• Ginger: Properly evidenced for nausea reduction. Tea, capsules, or fresh works.
• Anti-emetics: Occasional metoclopramide or ondansetron use can bridge particularly bad weeks. Discuss with us — we can prescribe short courses.

For constipation: fibre (psyllium husk, vegetables, fruit), water, gentle daily walking. Mild laxatives (lactulose or macrogol) if symptoms persist beyond a week.

When to call us

Most side effects don't need urgent input. These do:

• Severe abdominal pain (especially upper or right-upper)
• Persistent vomiting that prevents fluids staying down for more than 24 hours
• Jaundice (yellowing of skin or eyes)
• Dark urine and pale stools (gallbladder/bile duct signal)
• Severe injection site reaction with spreading redness, warmth or fever
• Signs of dehydration (dizziness on standing, low urine output, confusion)

Call 0161 258 6149 or our out-of-hours number. If you can't reach us and symptoms are severe, attend A&E and tell them you're on tirzepatide or semaglutide.

MHRA Drug Safety Update context

The MHRA has issued Drug Safety Updates for the GLP-1 class periodically since 2023. The headline points: contraception advice (tirzepatide may reduce oral contraceptive efficacy in the first weeks of treatment — use additional contraception), pancreatitis vigilance, gallbladder counselling, and the importance of stopping in pregnancy. These are reasonable, evidence-based updates rather than alarm signals. We discuss each at the start of treatment and again at follow-up.

Routine follow-up structure

Our standard structure: review at 4 weeks (titration assessment), 12 weeks (dose optimisation and progress), then quarterly. We also book a baseline blood panel and a 6-month repeat (see pre-Mounjaro baseline panel).

If you're travelling during treatment, our travelling with Mounjaro guide covers cold-chain and time-zone considerations.

How to book

If you're already on treatment and concerned about side effects, or considering starting and want to understand the full picture first, book a consultation at traffordclinic.co.uk/weight-loss or call 0161 258 6149. We're at Old Trafford with patients regularly from Manchester, Stretford, Sale, Altrincham, Rusholme and Salford Quays.

Related reading: Mounjaro vs Wegovy, Stopping Mounjaro.